192 related articles for article (PubMed ID: 38217008)
1. Improved cognition after rifaximin treatment is associated with changes in intra- and inter-brain network functional connectivity.
Casanova-Ferrer F; Gallego JJ; Fiorillo A; Urios A; Ríos MP; León JL; Ballester MP; Escudero-García D; Kosenko E; Belloch V; Montoliu C
J Transl Med; 2024 Jan; 22(1):49. PubMed ID: 38217008
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: implications for the gut-liver-brain axis.
Ahluwalia V; Wade JB; Heuman DM; Hammeke TA; Sanyal AJ; Sterling RK; Stravitz RT; Luketic V; Siddiqui MS; Puri P; Fuchs M; Lennon MJ; Kraft KA; Gilles H; White MB; Noble NA; Bajaj JS
Metab Brain Dis; 2014 Dec; 29(4):1017-25. PubMed ID: 24590688
[TBL] [Abstract][Full Text] [Related]
3. Selective improvement by rifaximin of changes in the immunophenotype in patients who improve minimal hepatic encephalopathy.
Mangas-Losada A; García-García R; Leone P; Ballester MP; Cabrera-Pastor A; Urios A; Gallego JJ; Martínez-Pretel JJ; Giménez-Garzó C; Revert F; Escudero-García D; Tosca J; Ríos MP; Montón C; Durbán L; Aparicio L; Montoliu C; Felipo V
J Transl Med; 2019 Aug; 17(1):293. PubMed ID: 31462286
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy.
Bajaj JS; Heuman DM; Sanyal AJ; Hylemon PB; Sterling RK; Stravitz RT; Fuchs M; Ridlon JM; Daita K; Monteith P; Noble NA; White MB; Fisher A; Sikaroodi M; Rangwala H; Gillevet PM
PLoS One; 2013; 8(4):e60042. PubMed ID: 23565181
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome is associated with poor response to rifaximin in minimal hepatic encephalopathy.
Ballester MP; Gallego JJ; Fiorillo A; Casanova-Ferrer F; Giménez-Garzó C; Escudero-García D; Tosca J; Ríos MP; Montón C; Durbán L; Ballester J; Benlloch S; Urios A; San-Miguel T; Kosenko E; Serra MÁ; Felipo V; Montoliu C
Sci Rep; 2022 Feb; 12(1):2463. PubMed ID: 35165326
[TBL] [Abstract][Full Text] [Related]
6. Non invasive blood flow measurement in cerebellum detects minimal hepatic encephalopathy earlier than psychometric tests.
Felipo V; Urios A; Giménez-Garzó C; Cauli O; Andrés-Costa MJ; González O; Serra MA; Sánchez-González J; Aliaga R; Giner-Durán R; Belloch V; Montoliu C
World J Gastroenterol; 2014 Sep; 20(33):11815-25. PubMed ID: 25206287
[TBL] [Abstract][Full Text] [Related]
7. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
[TBL] [Abstract][Full Text] [Related]
8. Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients.
Fiorillo A; Gallego JJ; Casanova-Ferrer F; Urios A; Ballester MP; San Miguel T; Megías J; Kosenko E; Tosca J; Rios MP; Escudero-García D; Montoliu C
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834174
[TBL] [Abstract][Full Text] [Related]
9. Aberrant salience network and its functional coupling with default and executive networks in minimal hepatic encephalopathy: a resting-state fMRI study.
Chen HJ; Chen QF; Liu J; Shi HB
Sci Rep; 2016 Jun; 6():27092. PubMed ID: 27250065
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of probiotics, rifaximin, and lactulose in the treatment of minimal hepatic encephalopathy and gut microbiota.
Wang MW; Ma WJ; Wang Y; Ma XH; Xue YF; Guan J; Chen X
Front Microbiol; 2023; 14():1091167. PubMed ID: 37032856
[TBL] [Abstract][Full Text] [Related]
11. Hippocampal atrophy and functional connectivity disruption in cirrhotic patients with minimal hepatic encephalopathy.
Lin W; Chen X; Gao YQ; Yang ZT; Yang W; Chen HJ
Metab Brain Dis; 2019 Dec; 34(6):1519-1529. PubMed ID: 31363985
[TBL] [Abstract][Full Text] [Related]
12. Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial).
Sidhu SS; Goyal O; Mishra BP; Sood A; Chhina RS; Soni RK
Am J Gastroenterol; 2011 Feb; 106(2):307-16. PubMed ID: 21157444
[TBL] [Abstract][Full Text] [Related]
13. Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: a randomized controlled trial.
Sharma K; Pant S; Misra S; Dwivedi M; Misra A; Narang S; Tewari R; Bhadoria AS
Saudi J Gastroenterol; 2014; 20(4):225-32. PubMed ID: 25038208
[TBL] [Abstract][Full Text] [Related]
14. Minimal Hepatic Encephalopathy in Indians: Psychometric Hepatic Encephalopathy Score and Inhibitory Control Test for Diagnosis and Rifaximin or Lactulose for Its Reversal.
Pawar VB; Surude RG; Sonthalia N; Zanwar V; Jain S; Contractor Q; Rathi PM
J Clin Transl Hepatol; 2019 Dec; 7(4):304-312. PubMed ID: 31915599
[No Abstract] [Full Text] [Related]
15. Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy.
Sidhu SS; Goyal O; Parker RA; Kishore H; Sood A
Liver Int; 2016 Mar; 36(3):378-85. PubMed ID: 26201713
[TBL] [Abstract][Full Text] [Related]
16. Minimal hepatic encephalopathy in cirrhosis- how long to treat?
Goyal O; Sidhu SS; Kishore H
Ann Hepatol; 2017 Jan-Feb 2017; 16(1):115-122. PubMed ID: 28051800
[TBL] [Abstract][Full Text] [Related]
17. Abnormal Regional Homogeneity and Functional Connectivity of Baseline Brain Activity in Hepatitis B Virus-Related Cirrhosis With and Without Minimal Hepatic Encephalopathy.
Sun Q; Fan W; Ye J; Han P
Front Hum Neurosci; 2018; 12():245. PubMed ID: 29988437
[No Abstract] [Full Text] [Related]
18. Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy.
Bajaj JS; Heuman DM; Wade JB; Gibson DP; Saeian K; Wegelin JA; Hafeezullah M; Bell DE; Sterling RK; Stravitz RT; Fuchs M; Luketic V; Sanyal AJ
Gastroenterology; 2011 Feb; 140(2):478-487.e1. PubMed ID: 20849805
[TBL] [Abstract][Full Text] [Related]
19. Selective impairments of resting-state networks in minimal hepatic encephalopathy.
Qi R; Zhang LJ; Xu Q; Zhong J; Wu S; Zhang Z; Liao W; Ni L; Zhang Z; Chen H; Zhong Y; Jiao Q; Wu X; Fan X; Liu Y; Lu G
PLoS One; 2012; 7(5):e37400. PubMed ID: 22662152
[TBL] [Abstract][Full Text] [Related]
20. Effects of SIBO and rifaximin therapy on MHE caused by hepatic cirrhosis.
Zhang Y; Feng Y; Cao B; Tian Q
Int J Clin Exp Med; 2015; 8(2):2954-7. PubMed ID: 25932262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
